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Abstract
The thyroid hormone receptor (TR) is a transcription factor that represses or activates
genes whose regulatory regions bear thyroid hormone (T3) response elements (TREs).
Modulation of this function requires shuttling into and out of the nucleus. This is
mediated by the binding of importins and exportins to amino acid sequences within
TR, called nuclear localization signals (NLSs) and nuclear export signals (NESs),
respectively. The fine balance between nuclear import, retention, and export of TR
has emerged as a critical control point for modulating T3-responsive gene expression,
including genes that control cell proliferation, differentiation, and apoptosis. NLS-
2 is a specific NLS located in the N-terminal A/B domain of TR-α1 and and its
oncogenic form v-ErbA. NLS-2 minimally consists of the basic residue-rich motif
KRKRK in TR-α1 of rats and humans. However, the flanking residues differ widely
among vertebrates, and are likely responsible for lack of a functional NLS-2 in TR-α1
in some species. Yet, systemic consequences of NLS-2 flanking sequence variation
remain unexplored. Further investigation of the NLS-2 variants and how these motifs
synergize with protein function will enhance understanding of how even a single amino
acid change can lead to TR mislocalization and potentially trigger oncogenesis.
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Chapter 1
Introduction
1.1 Nucleocytoplasmic Transport
The existence of membrane-bound organelles affords an extraordinary level of control
to eukaryotic cells. Compartmentalization allows for both spatial and temporal sep-
aration of the many processes occurring in a cell at any given moment. One of the
main partitions within the eukaryotic cell is between the nucleus and the cytoplasm,
where transcription and translation take place, respectively. As both processes are
reliant upon each other, transport between the nucleus and the cytoplasm is essential
and highly regulated. Examination of the pathways involved in nucleocytoplasmic
transport, as well as their mediating signals, may provide insight to diseases that
arise from malfunctioning of these critical processes.
1.1.1 Nuclear Pore Complex
The nucleus and the cytoplasm are separated by a lipid bilayer known as the nuclear
envelope. The outer layer is a continuation of the endoplasmic reticulum, while the
inner layer is lined by the nuclear lamina, composed of intermediate-filament lamin
proteins [Dingwall and Laskey, 1992]. Both layers are perforated and bound together
by nuclear pore complexes (NPCs), an ∼125 MDa protein complex composed of
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multiple copies of ∼30 different nucleoporin proteins (Nups) [Stoffler et al., 1999].
NPCs are the key structural component to nucleocytoplasmic trafficking, as they
provide the passageways through which cargo may be transported.
The NPC has eight-fold radial symmetry and can be divided into three rings: the
cytoplasmic ring and the nuclear ring, which sandwich a central ring that spans the
intermembrane space [Stoffler et al., 1999]. These rings encircle a channel of ∼35
nm in diameter [Strambio-De-Castillia et al., 2010]. Eight fibrils extend from the
cytoplasmic ring; likewise, eight rods ∼50 nm in length are directed outwards from the
nuclear ring and are joined distally by a ring, forming a basket-like structure [Stoffler
et al., 1999].
The diversity of Nups serve many functions. Nups in the cytoplasmic filaments
gather components of the translation machinery around the rim of the NPC to pro-
mote translation of mRNAs emerging from the central channel [Strambio-De-Castillia
et al., 2010]. Nups in the nuclear basket form a physical platform for transcriptional
regulators, chromatin remodelling complexes, SUMO machinery, and DNA repair
machinery [Strambio-De-Castillia et al., 2010, Ibarra and Hetzer, 2015]. In yeast,
actively transcribed genes have been shown to be tethered to NPCs, presumably al-
lowing for more rapid trafficking of the resulting mRNAs to the cytoplasm. The
association of certain genes with NPCs is driven by the presence of gene recruit-
ment sequences (GRSs) in their promoters. The Nup composition of metazoan NPCs
is highly dynamic [Rabut et al., 2004]. Fluorescence recovery after photobleaching
(FRAP) analyses indicate that peripheral Nups frequently travel to the interior of
the nucleus to interact with other areas of chromatin. During the early phases of
mitosis, as the nuclear envelope is broken down, NPCs are disassembled, and certain
Nups even relocate to kinetochores and assist in spindle formation [Ibarra and Hetzer,
2015].
Perhaps the Nups most critical to trafficking come from a family that bears
phenylalanine-glycine (FG) repeats. These FG-Nups each contain ∼20-30 repeats,
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which form long disordered strings, extending into and lining the central channel
[Stewart, 2007]. In total, a single NPC may contain ∼3,500 FG repeats. Whereas
small molecules may diffuse through the central channel, larger cargo (in the range of
40 kDa and above) must be complexed with carriers in order to pass through the FG-
repeat network, and cargo-carrier complexes have been shown to bind weakly with
FG-repeats. Several biophysical models have been proposed for the mechanism of
transport through the channel, some with firmer support than others. These models
must account for an impressive transport rate of ∼100 MDa/s, or ∼1,000 transloca-
tions/s, per NPC [Ribbeck and Go¨rlich, 2001].
The first model is the selective-phase model, which draws on an analogy of dif-
fusion through a lipid bilayer [Ribbeck and Go¨rlich, 2001]. Like the NPC, the lipid
bilayer excludes molecules above a certain size threshold from passing through. How-
ever, molecules with lipophilic properties, even if larger, are still able to diffuse into
and through the bilayer. Thus, the selective-phase model proposes that an intrinsic
property of cargo-carrier complexes allows them to diffuse into the hydrogel-like phase
formed by the FG-repeats. Interestingly, an in vitro gel formed of a single type of
FG-repeat is able to recapitulate many of the selective permeability properties of the
NPC, increasing the rate of transport of a cargo-carrier complex more than 25,000-
fold faster than cargo protein alone [Frey and Go¨rlich, 2007]. However, this rate is
dependent upon the complete saturation of the gel with FG-repeats, and may not be
representative of the in vivo composition of the NPC channel.
The oily-spaghetti model hypothesizes that FG-Nups form spaghetti-like strands
that line the channel of the nuclear pore [Macara, 2001]. Flexible and free-moving,
they nevertheless block the channel with their bulk. Cargo that is not bound to the
appropriate carrier slip off the spaghetti, while permissible cargo-carrier complexes
are able to interact with and jump randomly from one strand to another all the way
through the the channel. Directionality, however, remains a problem for this model.
The final model is perhaps also the most well-supported and appealing. The
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virtual-gate hypothesis can be represented with this quote from Rout et al.:“A hole
can be a barrier, even if a molecule is small enough to pass through it” [Rout et al.,
2003]. Essentially, a macromolecule has fewer microstates available when in the con-
fined channel of the NPC than when moving randomly in the periphery, and so there
is a decrease in entropy (S) for the macromolecule to enter the NPC. As entropy
drops (∆S < 0), change in Gibb’s free energy (∆G) becomes more positive, and thus
the process is less favored (see Equation 1.1).
∆G = ∆H − T∆S (1.1)
This entropic price is prohibitively high for macromolecules not bound to a carrier.
However, cargo-carrier complexes can interact with the FG-Nups, and in doing so,
the bond energy that is released (∆H < 0) can compensate for the loss in entropy.
It should be noted that the bond energy must not be too high, or else it would be
disfavored for the cargo-carrier complex to continue moving through the channel (i.e.,
it would get stuck to an FG-Nup). Indeed this is the case, for FG-Nup interactions
with cargo-carrier complexes are each relatively weak, although numerous [Stewart,
2007].
The virtual-gate hypothesis suggests, therefore, that spatial constraints drive
intermacromolecular interactions in the NPC channel. Interestingly, whereas the
mean persistence length of an engineered molecule consisting solely of FG domains
is 3.9 ± 1.4A˚, approximately the length of a single residue (and thus testifying to
the extraordinary flexibility of FG domains), crowding these molecules results in the
formation of stiff, brush-like conformations, a visible decrease in entropy [Lim et al.,
2006].
Permissibility of transport defined by entropy, the directionality of transport ac-
cording to the virtual-gate hypothesis is driven simply by concentration differences
between the nucleus and the cytoplasm - specifically, the concentration of RanGTP
(see Section 1.1.2). Thus it should be expected that reversing the gradient of RanGTP,
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such that RanGTP levels are artificially higher in the cytoplasm than in the nucleus,
should reverse the direction of transport [Rout et al., 2003]. This was in fact demon-
strated in HeLa cells [Nachury and Weis, 1999].
A finding that remains puzzling for all three models, however, is that over half of
FG domains can be deleted without losing NPC functionality [Strawn et al., 2004].
Moreover, certain combinations of FG-Nups were absolutely essential, a point that
has yet to be factored into any of these models. Altogether, the NPC is an intricate
and unique macromolecular machine that not only is essential to, but also shapes the
process of nucleocytoplasmic transport.
1.1.2 General Nuclear Import Pathways
A general diagram of the nuclear import cycle and the recycling of factors involved in
the import process is shown in Figure 1.1. As mentioned previously in Sec 1.1.1, the
directionality of import depends upon the gradient of RanGTP, a small GTP-binding
protein that resides mainly in the nucleus. On the other hand, its hydrolyzed form,
RanGDP, exists almost exclusively in the cytoplasm. This is due to the localization
of RanGEF (Ran Guanine nucleotide Exchange Factor, also known as RCC1) solely
in the nucleus, where it exchanges the GDP on Ran for GTP, while RanGAP (Ran
GTPase-Activating Protein) is kept to the cytoplasm, where it promotes the hydroly-
sis of GTP→ GDP + Pi. Surprisingly, the input of energy during nucleocytoplasmic
trafficking is not used directly in the process; movement through the NPC itself does
not require the hydrolysis of any high-energy molecules. Rather, the RanGTP ↔
RanGDP energy exchange is used to set directionality and mark import and export
complexes [Stewart, 2007].
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Figure 1.1: Overview of the nuclear import cycle
Members of the karyopherin protein family are carriers that recognize motifs upon
cargo proteins that are markers for import or export, respectively termed nuclear
localization signals (NLSs) and nuclear export signals (NESs). Accordingly, karyo-
pherins are also frequently referred to as importins and exportins. Humans have at
least 20 karyopherins, whereas yeast have 14 [Pemberton and Paschal, 2005]. Among
the importins, Karyopherin-β members interact directly with the NPC, and may ei-
ther be bound to their cargo directly or through an adaptor protein, a member of the
Karyopherin-α family. While there are many variations, the classical import path-
way (which recognizes classical NLS motifs; see Section 1.1.4) is one of the most
well-characterized and involves Karyopherin-β1 (Importin-β1) and Karyopherin-α
(Importin-α).
Importin-α is a 60 kDa protein containing an N-terminal Importin-β1 binding
domain (IBB) followed by 10 consecutive armadillo (ARM) repeats, the 10th of which
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binds to cellular apoptosis susceptibility protein (CAS) [Conti et al., 1998, Goldfarb
et al., 2004]. Each ARM motif of importin-α is composed of three helices, and is
separated from the next by a 9A˚ translation and 30° rotation, forming a stacked
structure with a right-handed superhelical twist. The groove formed by this twist,
specifically between the second and eighth ARM motifs, contains highly conserved,
solvent-exposed tryptophan-asparagine pairs. This conservation serves a functional
purpose: ARMs 2-4 bind both monopartite and the first portion of bipartite NLSs,
and ARMs 7-8 coordinate with the latter portion of bipartite NLSs (see Section 1.1.4).
While tryptophan accommodates the aliphatic chain of lysine (a standard residue
found in NLSs), asparagine forms hydrogen bonds with the polypeptide backbone.
Aspartate and glutamate interspersed in the groove binding pockets help to neutralize
the positive charge of the NLSs.
The N-terminal IBB domain, consisting of residues 10-50, allows Importin-α to
bind to Importin-β1 [Go¨rlich et al., 1996]. When fused to the nucleoplasmin core
domain, the IBB domain alone was able to confer nuclear localization ability by linking
directly to Importin-β1; however, the fusion protein accumulated in the nucleus,
indicating that IBB plays no role in export. Further examination of the IBB domain
revealed an autoregulatory role: IBB contains an NLS-like motif, 49-KRRNV-53,
which interacts with the ARM repeats, although at lower affinity than to Importin-
β1 [Kobe, 1999]. When IBB is occupied by binding to Importin-β1, the ARM repeats
are also released from autoinhibition to bind actual cargo proteins. Thus, a temporal
order is established: Importin-α first complexes with Importin-β1, before picking up
cargo.
Once the ternary complex is formed, it translocates to the nucleus, with Importin-
β1 interacting with FG-Nups to allow passage through the NPCs (see Section 1.1.1).
Importin-β1 is composed of 18-20 stacked HEAT repeats, each with two helices [Stew-
art, 2007, Conti et al., 2006]. When RanGTP binds to Importin-β1 upon arrival in
the nucleus, the helicoidal pitch of Importin-β1 is increased, forcing Importin-α and
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the cargo to be released. The freed IBB domain now competes with the cargo NLS for
the ARM motifs. Nup2p/Nup50 likewise helps speed up the process of cargo dissoci-
ation by binding to two separate sites on Importin-α, one of which also overlaps with
ARM motifs and competes with the cargo [Matsuura et al., 2003]. Finally, RanGTP
and the exportin CAS displace Nup2p to form the export complex for recycling of
Importin-α [Matsuura and Stewart, 2005].
Meanwhile, Importin-β1 has also migrated back to the cytoplasm in the company
of RanGTP. In the cytoplasm, RanGAP promotes the hydrolysis of RanGTP, and
the resulting conformational changes force dissociation of both the Importin-β1 and
Importin-α export complexes. The hydrolyzed RanGDP is then returned to the
nucleus by NTF2 (Nuclear Transport Factor 2), where exchange of GDP for GTP is
again facilitated by RanGEF [Ribbeck et al., 1998]. Thus, the import cycle is reset.
1.1.3 Relevance of Transport
All nuclear proteins are synthesized in the cytoplasm, and must be transported into
the nucleus. This includes not only all transcription factors, but also proteins in-
volved in DNA replication, scaffolding, and nuclear structural integrity, among nu-
merous other functions. Thus, defects in nucleocytoplasmic transport can have severe
consequences on the viability of the cell or contribute towards oncogenic processes if
unchecked.
A well-known transcription factor implicated in tumorigenesis is p53, referred to
colloquially as “the guardian of the genome” because of its role as a major tumor
suppressor. Target genes of p53 are involved in the processes of DNA damage repair,
cell cycle regulation and arrest, and apoptosis. Its levels are limited by degradation
rather than production [Vogelstein et al., 2000]. Under normal conditions, p53 is kept
in check by MDM2, another shuttling factor, which can promote degradation of p53
by ubiquitination [Honda et al., 1997]. Interestingly, while degradation occurs solely
in the cytoplasm, p53 must first be “primed” for degradation in the nucleus [O’Keefe
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et al., 2003]. Thus, nucleocytoplasmic shuttling is vital to maintenance of cellular
p53 levels.
When a cell is exposed to stress, p53 localizes to the nucleus, where it subsequently
tetramerizes [O’Brate and Giannakakou, 2003]. This conformational change shields
its nuclear export signal (NES), so that it can remain in the nucleus long enough to
perform its functions. The importance of localization is exemplified in tumors with
p53 abnormally confined to the cytoplasm, and which are consequently less responsive
to radiation and chemotherapy treatments [O’Brate and Giannakakou, 2003, Moll
et al., 1995]. Besides activating stress-response genes, p53 also up-regulates MDM2,
thus completing a negative feedback loop. With three NLSs and two NESs, p53 has
a tightly regulated intracellular traffic pattern that is crucial to its proper function
as a tumor suppressor.
Although not a transcription factor, another protein whose localization is now
recognized to be of critical importance is p27, which is a cyclin-dependent kinase
(CDK) inhibitor. As such, p27 negatively regulates progression of the cell cycle,
and resides in the nucleus during G0 and G1 phases at high concentrations [Rosner
et al., 2007]. At the start of S phase, Akt phosphorylates p27 at several serine
residues. These phosphorylation events allow 14-3-3, a regulatory protein, to bind
to p27 and export it to the cytoplasm, physically separating p27 from its cyclin:cdk
targets and allowing the cell division to progress. It follows, therefore, that cancer
cells should sequester p27 to the cytoplasm, and this is indeed observed in Ras-
dependent lung tumorigenesis, as well as in metastatic melanomas [Denicourt et al.,
2007]. In contrast to p53, and further highlighting the complexity and importance of
intracellular localization, p27 is rarely deleted or rendered completely nonfunctional in
cancer cells; rather, upon accumulation in the cytoplasm, it is hypothesized to exhibit
oncogenic characteristics by rearranging the cytoskeleton and activating metastatic
properties.
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1.1.4 Nuclear Localization Signals (NLSs)
Nuclear localization signals are characterized by clusters of basic residues (lysines
and arginines, K and R respectively), and come in monopartite and bipartite forms.
The prototypical monopartite NLS is that of the simian virus 40 (SV40) large T-
antigen: PKKKRKV, while an example of a bipartite NLS is that belonging to
nucleoplasmin: KRPAATKKAGQAKKKK [Kalderon et al., 1984, Robbins et al.,
1991]. Notably, there is a 10-residue spacer region between the two clusters of basic
amino acids; the sequence of this spacer is not of critical importance - even the
two lysines may be mutated with no consequence to localization ability [Robbins
et al., 1991]. Length of the spacer region may be increased, but not decreased. This
corresponds to the structure of Importin-α, as ARM motifs 7 and 8 (which bind the
latter portion of bipartite NLSs) are located a set distance from ARM motifs 2-4 (see
Section 1.1.2) [Conti et al., 1998]. While proteins may perhaps contort to fit within
this distance, there is a much stricter limit on how much they can stretch to reach
both sites.
Multiple examples exist of the importance of context upon the efficiency of local-
ization. The activity of the SV40 NLS is disrupted by replacing the K in the third
position with threonine (T) [Kalderon et al., 1984]. However, this mutant can be
rescued by adding KR at 12 residues upstream (thus leaving a 10-residue spacer),
mimicking a bipartite motif [Makkerh et al., 1996]. This is consistent with other
observations that the requirements within either given half of bipartite motif are less
stringent than in a monopartite motif; a mutation in one part is rescued by its part-
ner, but a double mutation in both parts knocks out localization ability [Robbins
et al., 1991].
Surprisingly, basic residues are not the only ones to enhance localization ability.
A particularly strong monopartite NLS is that of c-Myc, which has only three basic
residues: PAAKRVKLD [Makkerh et al., 1996]. It was found that the PAA and
LD residues increase localization, but only when placed upstream and downstream of
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the main motif, respectively. The placement of the NLS in the context of the whole
protein is also likely influenced structurally. NLSs should be in accessible regions to
allow interaction with importins [Roberts et al., 1987]. Furthermore, multiple copies
of NLSs may be roughly additive. The rules for determining whether a sequence will
be a functional NLS are in no way clear at this point. What appear to be patterns are
broken by frequent exceptions, and further characterization is thus necessary. Some
examples of monopartite and bipartite NLSs are shown in Figure 1.2.
Figure 1.2: Monopartite and bipartite NLSs
1.2 Thyroid Hormone Receptor
The thyroid hormone receptor (TR) belongs to the large superfamily of nuclear recep-
tors, which are ligand-inducible transcription factors. With over 100 members of this
superfamily, the nuclear receptors modulate gene expression in response to a wide
variety of hormone ligands, including the steroid, thyroid, and retinoid hormones,
as well as vitamin D3 [McKenna et al., 1999]. The superfamily can be divided into
three subtypes based on the behavior of the receptor in its unliganded form. Type I
11
nuclear receptors encompass all of the steroid hormone-binding receptors, such as the
androgen receptor (AR), estrogen receptor (ER), and glucocorticoid receptor (GR).
In the absence of ligand, Type I receptors associate with heat shock proteins and are
inactive. In terms of localization, GR and AR tend to be cytoplasmic, whereas min-
eralocorticoid receptor (MR) has a whole cell distribution, and ER and progesterone
receptor (PR) are solely nuclear [Kumar et al., 2006].
Type II receptor include TR, as well as the receptors for retinoic acid (RAR:
all-trans ; RXR: 9-cis retinoic acid) and vitamin D3 [McKenna et al., 1999]. Type II
receptors interact with DNA even in the absence of ligand, but act as corepressors until
ligand is bound, at which point they become coactivators. Whereas Type I receptors
recognize palindromic sequences, generally as homodimers, Type II receptors bind
direct repeat sequences, as frequently as heterodimers. In particular, TR has been
observed both as a low-affinity homodimer complex, as a high-affinity heterodimer
complex with RXR, and also in heterodimers with RAR [Lazar, 1993]. Thus, homo-
and heterodimerization may serve as another level of expression control. Finally Type
III receptors are known as orphan receptors, because their ligands are yet unknown
[McKenna et al., 1999].
Originally, TR was believed to be found in the nucleus at all times due to its ability
to bind DNA without ligand. However, while TR has a nuclear steady-state distribu-
tion, its localization is actually dynamic; it rapidly shuttles between the nuclear and
cytoplasmic compartments, with the majority of its time spent in the nucleus [Bunn
et al., 2001]. When thyroid hormone is available, TR nuclear localization is enhanced,
possibly because of the availability of additional DNA binding sites for ligand-bound
TR. The intracellular distribution of TR also differs by isoform (see Section 1.2.1).
The complexity of the localization patterns for TR present an opportunity for addi-
tional modulation of gene expression in the ultimate goal of maintaining metabolic
homeostasis.
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1.2.1 Structure
Nuclear receptors have a general structure consisting of several domains, lettered A
through F. The N-terminal A/B domain is variable in sequence and length, and has
a transactivation function [Tsai and O’Malley, 1994]. Specifically, the transactivation
domain is located between residues 21 and 30 in the α isoform of TR, which interacts
with transcription machinery such as TFIIB [Hadzic et al., 1995]. Within this stretch
also lies a nuclear localization signal present only in the TR-α1 isoform, called NLS-2,
which is the focus of this study (see Section 1.4) [Mavinakere et al., 2012].
The C domain is the DNA-binding domain (DBD), and is comprised of two zinc
finger motifs to recognize and bind to thyroid hormone response elements (TREs)
[Tsai and O’Malley, 1994]. In some nuclear receptors, the C domain is also responsible
for dimerization, although not in TR. Next, the D domain is a flexible hinge region
connecting the DBD and the ligand-binding domain (LBD; E domain). In both TR-
α1 and TR-β1 isoforms, the D domain contains a bipartite NLS (NLS-1), which has
stronger targeting activity than NLS-2 [Mavinakere et al., 2012].
The E domain is responsible for binding ligands, such as thyroid hormone [Tsai
and O’Malley, 1994]. Broadly, the E domain also achieves dimerization and trans-
activation. The E domain of TR contains at least three nuclear export signals, two
of which are overlapping and spanning helices 3 and 6 (NES-H3 and H6, respec-
tively) [Mavinakere et al., 2012]. The third is located at the C-terminal end of the
LBD in helix 12 (NES-H12), which also holds a second transactivaton domain (AF-2).
The AF-2 domain is ligand dependent, and thus may mediate the switch between the
corepressor and coactivator functions of TR [Flamant et al., 2006]. Crystallographic
studies show that ligand binding causes H12 along with H3, 4, and 5 to fold into
a structure with a hydrophobic cleft, allowing for the recruitment of coactivators.
Finally, the C-terminal F domain, solely present in the α1 isoform, serves unknown
functions among nuclear receptors [Tsai and O’Malley, 1994].
In humans, TR-α and TR-β isoforms are encoded by the THRA and THRB genes,
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located in humans on chromosomes 17p and 3q, respectively [Albertson et al., 1989,
Anderson et al., 1993]. Isoforms range from approximately 400 to 500 residues in
length [Oetting and Yen, 2007]. TR-α1 is the primary product of THRA; however,
alternative splicing can generate TR-α2, which diverges from α1 40 residues from
the C-terminus [Lazar, 1993]. This isoform instead has 120 additional residues with
no known homology. A different splice variant generates TR-α3, another C-terminal
truncated form [Flamant et al., 2006]. Two alternative isoforms also result from an
internal promoter in intron 7 of THRA (TR-∆α1 and TR-∆α2). All TR-α isoforms
secondary to α are unable to bind thyroid hormone, and thus may function solely as
repressors.
Two separate promoters in THRB lead to the TR-β1 and TR-β2 isoforms [Williams,
2000]. In addition, a third promoter in the rat produces the β3 and ∆β3 isoforms.
With the exception of ∆β3, each of these isoforms can bind ligand. Because the TR-
β isoforms lack NLS-2 in the A/B domain, they tend to be slightly more cytosolic
in localization than TR-α. On the organismal level, whereas TR-α1 tends to have
higher expression in skeletal muscle and brown adipose tissue, TR-β1 is found at high
levels in the testis and brain, and TR-β2 is restricted to the anterior pituitary and
hypothalamus [Yen and Heart, 2001].
Finally, there is the oncogenic mutant of TR-α, v-ErbA, discovered in the avian
erythroblastosis virus (AEV). v-ErbA begins with a viral retroviral gag sequence,
which runs 12 residues into the A/B domain [Damm et al., 1989]. The NLS-2 motif
of v-ErbA is mutated to KHKRK (as opposed to KRKRK) and is thus rendered non-
functional; v-ErbA tends to have a more cytosolic distribution. In addition, residues
have been deleted from the C-terminus, resulting in an inability to bind thyroid hor-
mone. Without ligand binding, v-ErbA serves as a dominant negative oncoprotein
and corepressor, and promotes the formation of sarcomas and leukemias. Refer to
Figure 1.3 for a general diagram of TR-α1, TR-β1, and v-ErbA.
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Figure 1.3: Motifs and domains of the TR-α1 and TR-β1 isoforms, as well as oncogenic
mutant v-ErbA
1.2.2 Pathway and Activity
The hypothalamus-pituitary-thyroid axis controls thyroid hormone production and
secretion, and operates in a negative feedback loop to maintain metabolic home-
ostasis. The tripeptide thyrotropin releasing hormone (TRH) is synthesized by the
hypothalamus, and transported to the anterior pituitary gland via the hypophyseal
portal system [Yen and Heart, 2001]. Pituitary thyrotrope cells express TRH recep-
tors, and upon binding of this hormone, manufacture and secrete thyroid stimulating
hormone (TSH), a 28 kDa glycoprotein, which binds to TSH receptor in the thyroid
to activate expression of genes involved in thyroid hormone production. Figure 1.4
shows an overview of this pathway.
Thyroid hormone is synthesized in two forms, T3 and T4, containing three and four
iodines, respectively. Thyroid cells rely on a Na+/I- symporter to supply the iodide for
T3/T4 synthesis [Dai et al., 1996]. While T4 is the predominant form in circulation,
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T3 binds TR with higher affinity, and thus target cells have deiodinase enzymes to
remove the fourth iodide from the more abundant T4 [Yen and Heart, 2001]. Type I
deiodinases, found in the liver and kidney, convert T4 → T3 [Ko¨hrle, 2000]. The T3
produced by Type I deiodinases in the liver and kidney may be released into general
circulation, while that produced by Type II deiodinases in the brain, pituitary, and
brown adipose tissue is generally destined for intracellular usage.
Thyroid hormone in the bloodstream circulates back to the hypothalamus and
pituitary gland and negatively regulates further production of TRH and TSH in a
negative feedback loop. As stated in Section 1.2.1, the presence of thyroid hormone
triggers a conformational change in the ligand-binding domain of TR, such that it
switches from being a corepressor to a coactivator [Flamant et al., 2006], or vice versa
in the case of negative TREs. Genes under the control of TREs are often involved in
metabolism and energy usage.
Figure 1.4: Hypothalamus-pituitary-thyroid axis
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1.3 Techniques in Nucleocytoplasmic Transport
A variety of techniques are used to observe nucleocytoplasmic transport. Here, some
of those currently utilized by the Allison Lab will be reviewed, although part of the
goal of this project was to develop a novel assay to measure localization.
1.3.1 Fluorescent Fusion Constructs
The gene encoding a target protein may be cloned immediately upstream or down-
stream of a gene encoding a fluorescent protein such as GFP or mCherry. When the
plasmid is expressed, a single mRNA molecule that codes for both the target and
the fluorescent protein will be produced, and translated into a single protein - for
example, GFP-TR-α1. Cells expressing the fusion construct can be viewed under the
fluorescent microscope (see Section 2.7) and scored for subcellular localization of the
fusion protein.
1.3.2 Immunostaining
Immunostaining begins with antibodies specific either to the target protein itself or
to a common tag that is fused to the target protein, such as hemagglutinin (HA)
or Myc. Cells must be permeabilized to allow in the antibodies, and as such, it is
more difficult to capture live cell dynamics; however, use of a mild permeabilization
agent may render this possible. Following binding of the primary antibody (an hour
or longer), the secondary antibody is introduced, which recognizes constant regions
in the primary antibody and also is conjugated to a fluorescent tag. The secondary
antibody thus amplifies the signal of the primary antibody and also is visible under
fluorescence microscopy (see Section 2.7). Cells may then be scored for the nuclear
or cytoplasmic localization of the target protein.
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1.3.3 Fluorescence Recovery After Photobleaching (FRAP)
FRAP analyzes the mobility of a fluorescent-tagged target protein in live cells. A
laser at a high intensity focus is used to bleach a small region of a cell, after which
a weaker laser is used to observe the movement of unbleached proteins back into
the area. Frequently encountered in membrane proteins studies, this technique has
also been employed to obtain rates and diffusion constants for nucleocytoplasmic
transport.
1.4 Objectives
Current sequence-based methods to identify potential nuclear localization signals rely
on searching for clusters of basic residues, which are characteristic of NLS motifs. As
explained in Section 1.1.4, however, the context surrounding an NLS influences its
localization ability. NLS-2 is a specific nuclear localization signal present in the
A/B domain of TR-α1 isoform, with the sequence KRKRK. A mutant, nonfunctional
version with the sequence KHKRK also exists in v-ErbA, the oncogenic homologue of
TR-α1. Previous work done in the Allison Lab has shown that the flanking residues of
NLS-2 indeed may enhance or diminish localization ability; for example, aspartic acid
(D) in the vicinity of NLS-2 causes a cytoplasmic shift in localization [Mavinakere
et al., 2012]. However, proline (P) and leucine (L) may ameliorate this effect. This
project aims, therefore, to further characterize the flanking residues of NLS-2, taking
into account both amino acid type and position. The ultimate goal is to generalize
such patterns to other nuclear receptors, and beyond, to any shuttling protein.
1.4.1 Promega® Dual-Glo Luciferase Assay System
Flanking residues may exert certain effects only in the vicinity of other specific
residues; they are not necessarily independent or additive in effects. Thus, a large
number of amino acid permutations must be screened in order to perform a full char-
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acterization. While fluorescence microscopy of fusion constructs might suffice for a
few variations - and was indeed used for pilot studies, this technique quickly becomes
inviable due to time limitations. Thus a scalable assay must be developed.
The luciferase assay measures transcriptional output in the form of light. Lu-
ciferases catalyze reactions that emit light; thus, light intensity is a readout of lu-
ciferase levels, which itself is relatable to mRNA levels. The exact relationship is
likely to be an exponential function, since each mRNA can be translated multiple
times, and each luciferase can catalyze many reactions. A small difference in mRNA
levels should therefore be amplified.
To link nuclear localization ability to light output, the luciferase gene was designed
to be driven by an orthogonal promoter that is recognized by a unique transcription
factor that is unable to localize independently, but may do so with a functional NLS
(see Figure 1.5). A unique transcription factor can be designed either with TAL
effectors (see Section 1.4.2) or dCas9-VP64; here TAL effectors were chosen.
Figure 1.5: The localization of a transcription factor bearing an NLS-2 variant will be
assessed by luciferase expression and light output
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The Promega® Dual-Glo Luciferase Assay System takes advantage of two kinds of
luciferases which bind different substrates. Firefly luciferase converts beetle luciferin
to oxyluciferin in the presence of Mg+, ATP, and O2, releasing light in the process.
Renilla luciferase (isolated from the sea pansy) converts coelenterazine to coelen-
teramide in the presence of O2, also releasing light (see Figure 1.6). A simple increase
or decrease in light output does not preclude the possibility of cell death, division,
or unequal seeding counts to be the root cause of the difference. However, having
two different luciferases allows one to act as an internal control. In this case, Renilla
luciferase (Rluc) is constitutively driven under the Herpes simplex virus thymidine
kinase (TK) promoter, while firefly luciferase (luc2P) is inducible. Firefly readings
are normalized to corresponding Rluc readings to ensure that it is a true induction
effect, rather than due to other reasons.
Figure 1.6: Reactions for firefly luciferase and Renilla luciferase
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1.4.2 Transcription Activator-Like Effectors (TALEs)
Transcription Activator-Like Effectors (TALEs or TAL effectors) comprise a large
family of effectors native to Xanthomonas, a genus of Gram-negative plant pathogens
that can damage leaves locally or invade the vasculature to cause systemic blight
disease [Boch and Bonas, 2010]. In fact, the potential for damage to the agricultural
industry by certain strains of Xanthomonas is so great that in 2008, Xanthomonas
oryzae was added to the USDA list of select agents with possible uses for bioterror-
ism. Xanthomonas employs the type III secretion system to inject virulence factors,
including TAL effectors, across the cell wall and into the cytoplasm of its host. The
characterization of the first TAL effector, AvrBs3, was complicated by the fact that
the encoding sequence had high GC content and contained a surprising number of
repeats.
Things became more intriguing when eukaryotic nuclear localization signals were
found in the C-terminal domain along with an activation domain [Boch and Bonas,
2010]. The true function of AvrBs3 was then revealed: it and other TAL effectors
are translocated into the nucleus of the plant host cell, where they force the expres-
sion of certain host genes to the benefit of Xanthomonas. It was next discovered
that each 34-residue repeat motif coded for recognition of a specific base, and when
these repeats are strung together in an array, the resulting TAL effector binds to a
corresponding DNA sequence with relatively high fidelity [Boch and Bonas, 2010,San-
jana et al., 2012]. Interestingly, 32 amino acids of each repeat are for the most part
identical, or have little consequence if they are not. These regions form two helices,
and the chain of these helical motifs are arranged into a superhelical conformation
that wraps around the curvature of the DNA helix. The base specificity is encoded
by only the 12th and 13th residues of each repeat, which are known as the repeat
variable diresidues (RVDs); for example, HD (histidine-aspartic acid) recognizes cy-
tosine [Boch and Bonas, 2010,Zhang et al., 2011]. Unfortunately, there are no RVDs
that are specific for guanine-only, so synthetic target sequences tend to avoid G if pos-
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sible [Boch and Bonas, 2010]. Furthermore, a cryptic site in the constant front region
recognizes thymine, and therefore all target sequences must begin with T. However,
a TAL effector code was generated, and based on this code, new TAL effectors can
be synthesized to bind specific sequences desired by the researcher.
Figure 1.7: Design and target sequence of TALE8
It is important in synthetic biology to maintain orthogonality of systems and avoid
unintended crosstalk. Using computational screening methods, Garg et al. identified
180 20-mer sequences that differ by at least 3 bp from any promoter region in the
human genome and generated TAL effectors targeting several of these 20-mers [Garg
et al., 2012]. The best characterized of these, TALE8, was selected for the purposes of
this project. As shown by Garg et al., TALE8 has 85-fold induction of a CFP reporter
bearing its target sequence, and very little off-target activity (see Figure 1.7). While
the native TAL effector contains an activation domain, here the strong viral VP64
activation domain was used instead. Likewise, the endogenous NLSs were replaced
with the strong SV40 NLSs.
1.4.3 Library Generation
The TALE8 constructs with the SV40 NLSs serve as a positive control for the lu-
ciferase assay, as they are known to localize very efficiently. However, NLS-2 is a
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weak NLS in comparison, and it is important that this assay be able detect more
subtle differences in localization ability. A more practical range of difference that
would ideally be resolved may be between the v-ErbA mutant non-functional NLS-2
and that of the brown rat (Rattus norvegicus), a long-time standard that is known
to have localization ability [Mavinakere et al., 2012]. In addition, permutations of
flanking sequences must be able to be created and swapped in easily. These may be
generated in the future using custom DNA synthesis services.
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Chapter 2
Methods
2.1 Computational Extraction of NLS-2 Sequences
From the NCBI Protein Blast database, 158 records containing the NLS-2 motif
KRKRK were downloaded into a text file. The accession number, species name, and
amino acid sequence +/- 10 residues upstream/downstream of KRKRK were written
to a csv file using a Python script generated for this project (see Appendix, Section
5.1). A total of 91 unique species were captured.
2.2 Construct Design and Subcloning
Vector and insert plasmids were digested for 60 minutes at 37°C using NEB® Re-
striction Endonucleases, following NEB® protocols. Following the first restriction
cut, samples were processed using the QIAquick PCR Purification Kit (Qiagen). Af-
ter the second restriction cut, digests were run out on agarose gels (default 0.7%
agarose; small inserts on 2%). Gels were stained with ethidium bromide and visual-
ized under UV. Figure 2.1 demonstrates the appearance of supercoiled (uncut) versus
linearized plasmid of the same size (note that in a cloning run, plasmids containing
the vector and inserts are cut twice, thus creating two fragments). Appropriate bands
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were excised and DNA fragments isolated using the QIAquick Gel Extraction Kit (Qi-
agen). Ligation reactions, performed with NEB® T4 DNA Ligase, were allowed to
proceed overnight at 16°C. Reactions were transformed into E. coli as described in
section 2.3.
Figure 2.1: Gel loading lanes:
1. NEB®2-log DNA ladder;
2. and 5. uncut 5SDM GeneArt. Bright band at ∼2.5 kb corresponds to supercoiled form.
Fainter bands at ∼5.5 kb and 4.5 kb may be concatamers.
3., 4., 6., and 7. single-cut 5SDM GeneArt. Bright band at ∼3.6 kb corresponds to linearized
form (note: DNA ladder uses linearized standards; thus, 3.6 kb is the true size of the
plasmid). Faint bands at ∼2.5 kb show undigested, supercoiled plasmid.
2.2.1 MBP-mCherry-NLS-2 Constructs
The Maltose Binding Protein (MBP) coding region was synthesized by the Thermo
Fisher Scientific Invitrogen GeneArt Gene Synthesis service. This encodes for a 391
amino acid protein (∼42 kDa), which serves as a large tag to prevent transport into
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the nucleus without recruitment and functionality of importins. The MBP GeneArt
was cloned into the multiple cloning site of the pmCherry-C1 vector (Clontech Labo-
ratories, Inc) by way of the XhoI and HindIII cutsites. The resulting MBP-mCherry
fusion protein is constitutively expressed in mammalian cell culture, as its encoding
gene is driven by the cytomegalovirus (CMV) promoter.
NLS-2 flanking sequences selected from five species as well as Rattus norvegicus
(see Table 3.1) were synthesized as GeneArt and subsequently cloned downstream
of MBP-mCherry with HindIII and KpnI. The final constructs produce an MBP-
mCherry fusion protein containing a C-terminal NLS-2 motif. A map of these con-
structs is shown in Figure 3.1.
2.2.2 pCMV6.AC-TALE8
The TALE8 binding array sequence was pieced together according to the TAL Effector
code specified in Garg et al. [Garg et al., 2012]. A constant front and back region
flank the binding array. Within the constant back region are two SV40 NLS motifs,
which will be swapped out for NLS-2 motifs in the future. Following the constant
back region is the VP64 activator and mCherry, separated by a T2A “self-cleaving”
peptide (it is thought that the ribosome skips the formation of a peptide bond at the
C-terminus of the T2A peptide, as opposed to autocatalytic behavior). The entire
TALE8 construct including VP64, T2A, and mCherry, was synthesized as GeneArt
and cloned into the pCMV6.AC vector (Origene) using HindIII and NotI, such that
its expression is driven by the constitutive CMV promoter.
2.2.3 pGL4.10-TALE8P
The TALE8 recognition sequence was synthesized as GeneArt and cloned into pGL4.10
(Promega®) using KpnI and HindIII, creating a TALE8-specific promoter upstream
of the luc2P gene encoding for firefly luciferase. The complete sequence with feature
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annotations is included in Appendix Section 5.3. A map of this construct is shown
in Figure 3.5.
2.2.4 pGL4.74 [hRLuc/TK]
This construct was obtained from Promega®. It consists of the hRluc gene encoding
for Renilla luciferase, driven by the constitutive Herpes simplex virus tyrosine kinase
(TK) promoter. A map of this construct is shown in Figure 3.6.
2.2.5 pCMV6.AC-TALE8-[NLS-2]-5SDM
The NsiI and SmaI cutsites flank the SV40 NLSs within TALE8, and must be used
in order to swap out SV40 NLS for NLS-2 variants. Ideally, the swap would occur
in the pCMV6.AC-TALE8 construct, as opposed to TALE8 gArt, which would then
have to be cloned back into the vector. However, two SmaI and three NsiI internal
cutsites exist in the pCMV6.AC vector. This is further complicated by the fact that
two of the NsiI sites are repeats of each other, so site-directed mutagenesis (SDM)
is not an option. Instead, a 1291 bp sequence encompassing all five internal cutsites
(mutated) had to be synthesized as GeneArt, and cloned into pCMV6.AC using NotI
and PstI to replace the original sequence. This GeneArt was named 5SDM.
In the meantime, NLS-2 sequences for Rattus norvegicus (called RN from this
point forward) and v-ErbA were synthesized and cloned into TALE8 using NsiI and
SmaI, generating TALE8-RN and TALE8-vErbA. Because in the final configuration,
TALE8 is directly adjacent to 5SDM and both share the NotI cutsite, this presented
the opportunity to conduct a 3-way ligation, in which TALE8-RN/vErbA and 5SDM
are cloned into pCMV6.AC simultaneously. This was attempted and clone sequencing
results are pending. The complete sequence with feature annotations is included in
Appendix Section 5.3. A map of this construct is shown in Figure 3.4.
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2.3 Plasmid Preparation
All plasmids with the exception of those containing TALE8 were propagated in
NEB® 5-alpha competent E. coli (C2987). Because TALE8 is rich in repeat ele-
ments, plasmids containing TALE8 were transformed into NEB® Stable competent
E. coli (C3040). C3040 has a genotype that minimizes the risk of recombination, due
to mutations in various recombinases. Protocols for C2987 and C3040 are similar;
however, all growth phases for C3040 are performed at 30°C as opposed to 37°C.
Transformation was performed with ∼ 200ng of DNA. Following a 30 minute
incubation on ice, cells underwent heat shock at 42°C for 30 seconds to promote
uptake of plasmid. An outgrowth phase of 1 hour at 37°C in SOC media preceded
spreading onto antibiotic selection plates. Plates were incubated overnight (24 hours
for C3040).
3mL starter cultures of LB media +antibiotic were inoculated with single colonies
and grown at 250rpm, 37°C / 30°C for up to 8 hours. 1mL of starter culture was
subsequently transferred to 50mL of LB media +antibiotic for overnight growth.
Overnight cultures were spun down at 6000×g for 10 minutes at 4°C. Pellets were
processed using the Zymo Research Zyppy Plasmid Midiprep Kit. Purified plasmid
was quantified using the Nanodrop® 1000.
2.4 Tissue Culture
HeLa (ATCC® CCL2) cells were grown in Gibco Minimum Essential Media (MEM)
supplemented with 10% fetal bovine serum at 37°C, 5% CO2 and 98% humidity. Cells
were allowed to reach ∼90% confluency before passaging or seeding for transfection.
For passaging, cells were rinsed with 1x D-PBS before dissociation with 0.25% trypsin.
A fraction of resuspended cells was transferred to the new flask.
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2.5 Seeding and Transfection
Cells were seeded at 2.5×105 cells/well into 6-well plates containing coverslips and
grown overnight. For each well, 4µL of Lipofectamine® 2000 (Thermo Fisher Scien-
tific) and 2µg total DNA were each diluted in 250µL Gibco Opti-MEM  I Reduced
Serum Media. Diluted Lipofectamine and diluted DNA were combined and incubated
for 20 minutes at room temperature to allow for liposome formation. Cells were incu-
bated with this transfection mixture for 8 hours before the media was replaced with
2mL of MEM. This was followed by an overnight growth phase.
96-well plates for luciferase assays were seeded at 2.0×104 cells/well in a volume
of 100µL. For each column of 8 wells, 5µL Lipofectamine® 2000 and 1µg total DNA
were each diluted in 50µL Gibco Opti-MEM  I Reduced Serum Media. Diluted
Lipofectamine and diluted DNA were combined and incubated for 20 minutes at
room temperature to allow for liposome formation. Each well received 100µL of the
DNA-liposomal complexes. Plates were incubated for 8 hours at normal growing
conditions before replacing media. A sample calculation for diluting DNA is shown
below:
Example: Col 1. pGL4.74 Rluc + pGL4.10-TALE8P + pCMV6.AC-TALE8:
333ng× µL
202ng
= 1.65µL pGL4.74 Rluc
333ng× µL
201ng
= 1.66µL pGL4.10-TALE8P
333ng× µL
205ng
= 1.62µL pCMV6.AC-TALE8
50µL− (1.65µL+ 1.66µL+ 1.62µL) = 45.07µL Opti-MEM
2.6 Fixation and Staining of Slides
Cells were washed 3× with 2mL 1x D-PBS per well, for 15 seconds per wash. Fixation
in 3.7% formaldehyde was allowed to proceed for 7 minutes. Following removal of
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formaldehyde, cells were washed again 3× in 1x D-PBS, for 5 minutes per wash.
Coverslips were inverted and mounted on glass slides using Fluoro-Gel II with DAPI
(Electron Microscopy Sciences).
2.7 Fluorescence Microscopy and Scoring
Slides were viewed on an inverted fluorescent microscope. Images were obtained using
Nikon® NIS-Elements microcope imaging software. To measure fluorescence inten-
sity, identical Regions of Interest (ROIs) were drawn in the nucleus using the DAPI
channel and the cytoplasm through the mCherry channel. The nuclear:cytoplasmic
fluorescence ratio was calculated by exporting intensity readings to Microsoft Excel.
2.8 Promega® Dual-Glo Luciferase Assay
Dual-Glo Luciferase Reagent was prepared according to manufacturer’s protocol,
aliquoted, and stored at -80°C. Dual-Glo Stop & Glo Reagent was prepared fresh
by diluting Stop & Glo Substrate 1:100 in Stop & Glo Buffer (100µL per well). At
26 hours post-transfection, media in wells was replaced with Gibco MEMα. MEMα
does not contain phenol red indicator and is colorless, which is crucial since the lu-
ciferase assay is based upon luminescence. Because the enzyme catalytic rates are
affected by temperature, the plate was left to equilibrate to room temperature before
simultaneous addition of 100µL of Luciferase Reagent per well (using a multichannel
pipette). The firefly luciferase reaction was allowed to proceed for 10 minutes. Lu-
minescence was measured with a plate reader (Promega GloMax®-Multi Microplate
Multimode Reader). Next, 100µL of Stop & Glo Reagent was added to each well to
quench the firefly luciferase reaction and provide substrate for the Renilla luciferase
reaction, which likewise proceeded for 10 minutes before reading luminescence.
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Chapter 3
Results
3.1 NLS-2 Species Variants
The TR sequences from a total of 91 species were downloaded from NCBI and the
NLS-2 flanking sequences were extracted (see Appendix, Section 5.2). From this large
group, six species with very different flanking sequences were selected (see Table 3.1).
These sequences were cloned into the MBP-mCherry vector (see Figure 3.1) and were
scored under the microscope.
Table 3.1: NLS-2 species variants in pilot study.
Red = Nonpolar; green = Polar; blue = Acidic; purple = Basic.
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Figure 3.1: Construct design for MBP-mCherry-[NLS-2]
Figure 3.2: Aggregate formation with the MBP-mCherry vector. Outlines of cells are drawn
to indicate where the cytoplasm ends. The red and green boxes in the top right corner are
the ROIs.
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Slides were blinded. Unfortunately, the MBP-mCherry formed aggregates, thus
making the slides difficult to score in an unbiased manner (see Figure 3.2). When
selecting Regions of Interest, aggregates were purposely avoided, since these were not
uniformly representative of the cell.
Fifty cells were scored from each slide; each slide set contained two each of the six
chosen species as well as empty vector. The nuclear:cytoplasmic ratio of fluorescence
intensity was averaged between the two slides. Three slide sets were scored in total
(see Figure 3.3). Variance was very high between replicates. An Analysis of Variance
(ANoVA) test was performed, which found that there are no significant differences in
localization between the constructs (p = 0.07332).
However, the specific variations that were chosen in this pilot study are only a
small fraction of the possible flanking residue permutations. The amount of time to
collect data using microscopy would be infeasible for a scaled approach. Thus, it was
decided to proceed with designing the modified luciferase assay.
Figure 3.3: Nuclear:cytoplasmic ratios for NLS-2 species constructs
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3.2 Modified Luciferase Assay
The TALE8 recognition sequence (TALE8P) as well as the sequence encoding for
TALE8 were designed and submitted for synthesis. NLS-2 sequences for Rattus
norvegicus and v-ErbA were also synthesized. These will serve as the intended upper
and lower bounds of detection, respectively. Subcloning was performed according
to the designs in figures 3.4, 3.5, and 3.6. The 5SDM cassette is only required to
swap out NLSs in the future, since it removes the internal cutsites for NsiI and SmaI.
Thus, the very first pCMV6.AC-TALE8 construct carried SV40 NLSs and no 5SDM
cassette (referred to as pCMV6.AC-TALE8-SV40). It is a “dead-end” construct in
the sense that it is unsuitable for NLS-2 swaps and will no longer be used once the
5SDM constructs are successfully subcloned. However, in the meantime, pCMV6.AC-
TALE8-SV40 was used as a positive control for the first luciferase assays.
Three luciferase assays were performed to establish the absolute upper and lower
bounds for nuclear localization detection. The absolute lower limit is set by the
empty pCMV6.AC vector, which has no localization ability; the upper limit is set by
pCMV6.AC-TALE8-SV40, since SV40 NLS is widely accepted to have exceptionally
strong localization ability. Four wells in each column were transfected. Columns were
set up as follows:
Column 1: Column 3:
pGL4.74 [hRluc/TK] pGL4.74 [hRluc/TK]
pGL4.10-TALE8P pGL4.10-TALE8P
pCMV6.AC-TALE8-SV40 pCMV6.AC (empty vector)
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Figure 3.4: Construct design for pCMV6.AC-TALE8-[NLS-2]
Figure 3.5: Construct design for pGL4.10-TALE8P
Figure 3.6: Construct design for pGL4.74 [hRluc/TK]
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luc2P Readings
1 3
A 2.4028× 106 2.2621× 104
B 2.3669× 106 2.3148× 104
C 1.8707× 106 2.4680× 104
D 1.5150× 106 2.3395× 104
hRluc Readings
1 3
A 3.7591× 104 2.3738× 104
B 5.3261× 104 3.2197× 104
C 6.3227× 104 3.1350× 104
D 4.6875× 104 1.2155× 104
luc2P : hRluc Ratio
1 3
A 63.92 0.95
B 44.44 0.72
C 29.59 0.79
D 32.32 1.92
Average 42.57 1.10
Table 3.2: 170215 luciferase assay run
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luc2P Readings
1 2 3
A 9.0718× 105 4.8231× 103 1.0584× 104
B 6.4901× 105 5.4014× 103 8.7417× 103
C 4.9778× 105 4.2889× 103 7.3246× 103
D 3.8430× 105 3.1025× 103 6.2459× 103
hRluc Readings
1 2 3
A 2.9982× 104 4.5401× 102 2.4453× 104
B 1.7375× 104 4.4201× 102 1.9292× 104
C 1.0153× 104 4.2801× 102 1.4907× 104
D 9.5765× 103 3.3801× 102 9.7897× 103
luc2P : hRluc Ratio
1 2 3
A 30.26 10.62 0.43
B 37.35 12.22 0.45
C 49.03 10.02 0.49
D 40.13 9.18 0.64
Average 39.19 10.51 0.50
Table 3.3: 170428 luciferase assay run
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luc2P Readings
1 3
A 1.5526× 106 1.9412× 104
B 1.3867× 106 2.2002× 104
C 1.4380× 106 2.0507× 104
D 1.2544× 106 1.7713× 104
hRluc Readings
1 3
A 4.5706× 104 3.3136× 104
B 4.2326× 104 2.7641× 104
C 3.9010× 104 2.5574× 104
D 4.0079× 104 2.4604× 104
luc2P : hRluc Ratio
1 3
A 33.97 0.59
B 32.76 0.80
C 36.86 0.80
D 31.30 0.72
Average 33.72 0.73
Table 3.4: 170501 luciferase assay run
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For the first luciferase run (170215, see Table 3.2), reagents were added individ-
ually to each well, resulting in a considerable time delay between A1 and D3. In an
enzyme-catalyzed reaction, a few minutes can make a large difference. Nevertheless,
there is a consistent trend such that wells transfected with pCMV6.AC-TALE8-SV40
have more than an order of magnitude fold difference in luc2P:hRluc luminescence
ratio over wells transfected with empty vector. Furthermore, hRluc readings were
fairly constant between Columns 1 and 3, indicating that there were no issues with
increased cell death rate due to the TAL effector. Thus, these preliminary results sug-
gested that TALE8 was successfully localizing to the nucleus and binding its target
sequence.
Due to the timing issues in the first trial, a multi-channel pipette was used for the
170428 run (see Table 3.3). However, other issues arose due to human error. Misla-
beling of columns led to confusion over whether Column 2 or Column 3 on the plate
contained the pCMV6.AC vector (the other column was entirely devoid of cells). The
reaction was carried out anyway, with reagent added to Columns 1-3, since the empty
column should be identifiable by much lower hRluc readings than the two transfected
columns. It is thus hypothesized that Column 2 was actually empty. There was unfor-
tunately another confounding variable, however: an insufficient amount of luciferase
reagent was thawed to account for the loss in the trough for the multi-channel pipette.
Thus, there was a further time delay for Column 2, as more luciferase reagent had to
be thawed mid-experiment. Due to this multitude of errors, the 170428 run should
be discounted.
Based on the experience of the first two trials, the 170501 run was carried out
with no issues (see Table 3.4). Once again, there is a consistent ∼30-fold induction
of luc2P luminescence over hRluc in wells containing pCMV6.AC-TALE8-SV40.
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Chapter 4
Discussion
Results from the initial pilot studies done using the MBP-mCherry-[NLS-2] constructs
were unreliable due to aggregation of the fluorescent fusion protein. Aggregates pose
a major problem, as they not only interfere with normal cellular function, but also
lead to sequestration and depletion of the protein of interest from both the nuclear
and cytoplasmic compartments, although not necessarily equivalently. Thus, it is
impossible to deconvolute aggregation effects from true localization differences using
fluorescence intensity measurements. It is known that fusion constructs with certain
fluorescent proteins form aggregates that are artifacts of the fluorescent proteins them-
selves rather than indicative of cellular functionality [Landgraf et al., 2012]. mCherry
is a particularly bad offender, and may have had some contribution towards the large
foci observed with MBP-mCherry.
With this in mind, constructs for a modified luciferase assay were designed and
assembled. The goal of this assay was to provide light output in response to enhanced
nuclear localization ability, utilizing TAL effectors that bear NLS-2 flanking sequence
variants. At this point, absolute positive and negative controls, relying on SV40 NLS
and empty vector respectively, have been tested, and provide a satisfactory range of
fold-induction readings.
It remains to be seen whether the induction difference between two weak NLSs
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will be able to be resolved using the modified luciferase assay developed in this thesis
research. The NLS-2 sequences from Rattus norvegicus and v-ErbA have successfully
been cloned into TALE8, and are currently being inserted into the pCMV6.AC vector
along with 5SDM, which will be required to swap in other NLS-2 variants at a later
time. In the meantime, it is necessary to verify that this reporter system does not
interfere excessively with normal cellular function.
While the mCherry tag in the TALE8 constructs was designed to break from
the TALE8 protein via the T2A peptide overexpressing a non-native protein can,
in general, cause aggregation problems that are stressful for the cell. Altered gene
expression as part of the stress response can then be a confounding factor for the
experiment. TALE8 is a large protein that is non-native to mammalian cell culture,
and it is being driven by a strong viral promoter (CMV). Thus, it is reasonable to be
concerned about toxicity. To check for these effects, 6-well plates can be transfected
with pCMV6.AC-TALE8-SV40. Cells may then be viewed under the fluorescent mi-
croscope to examine morphology. Aggregation of the mCherry tag should also be
visible if present.
Assuming that it is determined that this modified luciferase assay is suitable for
detecting subtle differences in localization ability, the next step would be to consider
ways to generate a library of pCMV6.AC-TALE8-[NLS-2]-5SDM constructs with a
wide variety of NLS-2 variants. Certain gene synthesis services offer screening library
oligonucleotide design. Originally, it was intended to make use of these services, and
then rapidly generate the library via Gibson Assembly. However, TAL effectors are
incompatible with PCR-based methods due to their repetitive elements and high GC
content. Thus, it would be necessary to subclone the library by restriction enzyme
digest, using the NsiI and SmaI cutsites. While much less convenient, it remains a
viable option at this point.
Throughout the course of this project, the difficulties of working with TAL ef-
fectors were encountered. The repeats that were originally attractive due to their
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(relatively) simple code and modularity also pose challenges due to recombination
and the near impossibility of performing PCR-based methods. While considerably
easier and cheaper to use than their predecessors, the zinc finger nucleases, TAL ef-
fectors have largely been superseded by CRISPR-Cas9 technologies for good reason.
The CRISPR-Cas9 system, like TAL effectors, allows the targeting of specific
sequences, and was evolved in prokaryotes [Jinek et al., 2012]. Unlike TAL effectors
where specificity is encoded into the amino acid sequence, Cas9 is directed to its
target via complementary guide RNAs (gRNAs). The design of the gRNA is critical
to the success of the experiment and was originally judged to be more complex than
the design of the TAL effector. Thus, TAL effectors were chosen for this project.
However, Perez-Pinera et al. modified the Cas9 enzyme such that it is unable to
cut due to two mutations (D10A and H840A) and which has also been fused to
a VP64 activation domain [Perez-Pinera et al., 2013]. dCas9-VP64 functions as a
customizable, targeted transcription factor, and may be worth further investigation
as a less cumbersome alternative for TAL effectors in the future of this project.
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Chapter 5
Appendix
5.1 Python script for extracting NLS-2 sequences
#!/usr/bin/env python
import re
import csv
f1=open("seqdump.txt","r")
f2=open("NLS.txt","w")
print("File opened")
for line in f1:
no_line_breaks=line.replace("\n", "").replace(">", "\n>")\
.replace("\n\n>","\n>")
f2.write(no_line_breaks)
f1.close()
f2.close()
f2=open("NLS.txt","r")
with open("NLS_10.csv","a+",newline="") as f:
writer=csv.writer(f)
writer.writerow(["Accession Number","Species","Motif Sequence"])
for line in f2:
species=re.search("\[(.*)]", line)
if species:
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print(species.group(1))
motif=re.search("..........KRKRK..........", line)
gi=re.search("gi\|(.*)\|", line)
if motif:
print(motif.group(0))
print(gi.group(0))
writer.writerow(
[gi.group(0),species.group(1),motif.group(0)])
print("row written")
else:
print("no motif")
else:
continue
f2.close()
f.close()
5.2 NLS-2 Species Variants
The following six pages contain all NLS-2 variants downloaded from NCBI, as run
through the Python script to extract accession numbers, species names, and flank-
ing sequences +/- 6 residues about the KRKRK motif (a later modification of the
script pulled +/- 10 residues). Common names were added manually by Dr. Allison.
Entries are arranged in alphabetical order by motif sequence; alternating red and
blue coloration was added for convenience, to distinguish where a change in sequence
occurred, since many species shared flanking sequences. Yellow highlighted entries
indicate sequences that were cloned into the MBP-mCherry vector.
44
Accession Number Species Motif Sequence Common name
gi|586448917|ref|XP_006832639.1| Chrysochloris asiatica ARSPDGKRKRKNGQCPL Cape golden mole
gi|507664863|ref|XP_004707188.1| Echinops telfairi ARSPDGKRKRKNGQCPL Lesser hedgehog tenrec 
gi|50392|emb|CAA30577.1| Mus musculus ARSPDGKRKRKNGQCPL House mouse
gi|50390|emb|CAA30576.1| Mus musculus ARSPDGKRKRKNGQCPL House mouse
gi|148684217|gb|EDL16164.1| Mus musculus ARSPDGKRKRKNGQCPL House mouse
gi|55932|emb|CAA31237.1| Rattus norvegicus ARSPDGKRKRKNGQCPL Brown rat
gi|207301|gb|AAA42238.1| Rattus norvegicus ARSPDGKRKRKNGQCPL Brown rat
gi|149054133|gb|EDM05950.1| Rattus norvegicus ARSPDGKRKRKNGQCPL Brown rat
gi|52001262|sp|P63059.1| Rattus norvegicus ARSPDGKRKRKNGQCPL Brown rat
gi|301779113|ref|XP_002924975.1| Ailuropoda melanoleuca ARSPDGKRKRKNGQCSL Giant panda
gi|528767514|gb|EPY87173.1| Camelus ferus ARSPDGKRKRKNGQCSL Bactrian camel
gi|478520773|ref|XP_004434600.1| Ceratotherium simum simum ARSPDGKRKRKNGQCSL White rhinoceros
gi|635092609|ref|XP_008010996.1| Chlorocebus sabaeus ARSPDGKRKRKNGQCSL Green monkey
gi|537142061|gb|ERE68311.1| Cricetulus griseus ARSPDGKRKRKNGQCSL Chinese hamster
gi|625254370|ref|XP_007618524.1| Cricetulus griseus ARSPDGKRKRKNGQCSL Chinese hamster
gi|344256923|gb|EGW13027.1| Cricetulus griseus ARSPDGKRKRKNGQCSL Chinese hamster
gi|488516382|ref|XP_004450183.1| Dasypus novemcinctus ARSPDGKRKRKNGQCSL Nine-banded armadillo
gi|585672135|ref|XP_006889469.1| Elephantulus edwardii ARSPDGKRKRKNGQCSL Cape elephant shrew
gi|667298343|ref|XP_008580252.1| Galeopterus variegatus ARSPDGKRKRKNGQCSL Sunda flying lemur
gi|667298340|ref|XP_008580251.1| Galeopterus variegatus ARSPDGKRKRKNGQCSL Sunda flying lemur
gi|667298349|ref|XP_008580254.1| Galeopterus variegatus ARSPDGKRKRKNGQCSL Sunda flying lemur
gi|512995839|ref|XP_004859513.1| Heterocephalus glaber ARSPDGKRKRKNGQCSL Naked mole rat
gi|512995837|ref|XP_004859512.1| Heterocephalus glaber ARSPDGKRKRKNGQCSL Naked mole rat
gi|351709120|gb|EHB12039.1| Heterocephalus glaber ARSPDGKRKRKNGQCSL Naked mole rat
gi|62088272|dbj|BAD92583.1| Homo sapiens ARSPDGKRKRKNGQCSL Human
gi|216409680|dbj|BAH02277.1| Homo sapiens ARSPDGKRKRKNGQCSL Human
gi|325495529|gb|ADZ17370.1| Homo sapiens ARSPDGKRKRKNGQCSL Human
gi|825639|emb|CAA38899.1| Homo sapiens ARSPDGKRKRKNGQCSL Human
gi|119581038|gb|EAW60634.1| Homo sapiens ARSPDGKRKRKNGQCSL Human
gi|6018474|emb|CAB57886.1| Homo sapiens ARSPDGKRKRKNGQCSL Human
gi|507543033|ref|XP_004655508.1| Jaculus jaculus ARSPDGKRKRKNGQCSL Lesser Egyptian jerboa
gi|524952016|ref|XP_005076009.1| Mesocricetus auratus ARSPDGKRKRKNGQCSL Golden hamster
gi|524952014|ref|XP_005076008.1| Mesocricetus auratus ARSPDGKRKRKNGQCSL Golden hamster
gi|532051129|ref|XP_005368323.1| Microtus ochrogaster ARSPDGKRKRKNGQCSL Prairie vole
gi|521023245|gb|EPQ05033.1| Myotis brandtii ARSPDGKRKRKNGQCSL Brandt's bat
gi|558179261|ref|XP_006100884.1| Myotis lucifugus ARSPDGKRKRKNGQCSL Little brown bat
gi|504159972|ref|XP_004591223.1| Ochotona princeps ARSPDGKRKRKNGQCSL American pika
gi|504159970|ref|XP_004591222.1| Ochotona princeps ARSPDGKRKRKNGQCSL American pika
gi|504159968|ref|XP_004591221.1| Ochotona princeps ARSPDGKRKRKNGQCSL American pika
gi|466072852|ref|XP_004282802.1| Orcinus orca ARSPDGKRKRKNGQCSL Orca (killer whale)
gi|466072847|ref|XP_004282801.1| Orcinus orca ARSPDGKRKRKNGQCSL Orca (killer whale)
gi|634851532|ref|XP_007940253.1| Orycteropus afer afer ARSPDGKRKRKNGQCSL Aardvark
gi|169743241|gb|ACA66242.1| Oryctolagus cuniculus ARSPDGKRKRKNGQCSL European rabbit
gi|169743243|gb|ACA66243.1| Oryctolagus cuniculus ARSPDGKRKRKNGQCSL European rabbit
gi|395826488|ref|XP_003786450.1| Otolemur garnettii ARSPDGKRKRKNGQCSL Northern greater galago
gi|410051368|ref|XP_003953077.1| Pan troglodytes ARSPDGKRKRKNGQCSL Common chimpanzee
gi|402900084|ref|XP_003913010.1| Papio anubis ARSPDGKRKRKNGQCSL Olive baboon
gi|395749222|ref|XP_002827659.2| Pongo abelii ARSPDGKRKRKNGQCSL Sumatran orangutan
gi|4138570|emb|CAA06702.1| Sus scrofa ARSPDGKRKRKNGQCSL Wild boar
gi|60813032|gb|AAX36243.1| synthetic construct ARSPDGKRKRKNGQCSL Synthetic construct
gi|61365614|gb|AAX42736.1| synthetic construct ARSPDGKRKRKNGQCSL Synthetic construct
gi|224487813|dbj|BAH24141.1| synthetic construct ARSPDGKRKRKNGQCSL Synthetic construct
gi|471380645|ref|XP_004378118.1| Trichechus manatus latirostris ARSPDGKRKRKNGQCSL Florida manatee
gi|471380643|ref|XP_004378117.1| Trichechus manatus latirostris ARSPDGKRKRKNGQCSL Florida manatee
gi|444714013|gb|ELW54901.1| Tupaia chinensis ARSPDGKRKRKNGQCSL Chinese tree shrew
gi|470599606|ref|XP_004311984.1| Tursiops truncatus ARSPDGKRKRKNGQCSL Common bottlenose dolphin
gi|219688698|dbj|BAH09862.1| Solea senegalensis GWLNGPKRKRKNSQCSV Senegal sole
gi|657803672|ref|XP_008328935.1| Cynoglossus semilaevis GWPDVPKRKRKNSLCSV Tongue sole
gi|645170795|gb|AIB06352.1| Cynoglossus semilaevis GWPDVPKRKRKNSLCSV Tongue sole
gi|145315395|gb|ABP62960.1| Epinephelus coioides GWPDVPKRKRKNSQCSM Orange spotted grouper
gi|4929197|gb|AAD33899.1| Hippoglossus hippoglossus GWPDVPKRKRKNSQCSM Atlantic halibut
gi|416422|dbj|BAA03928.1| Paralichthys olivaceus GWPDVPKRKRKNSQCSM Olive flounder
gi|617450248|ref|XP_007568329.1| Poecilia formosa GWPDVPKRKRKNSQCSM Amazon molly
gi|617450245|ref|XP_007568328.1| Poecilia formosa GWPDVPKRKRKNSQCSM Amazon molly
gi|658861433|ref|XP_008413479.1| Poecilia reticulata GWPDVPKRKRKNSQCSM Guppy
gi|658861430|ref|XP_008413478.1| Poecilia reticulata GWPDVPKRKRKNSQCSM Guppy
gi|55832824|gb|AAV66919.1| Pseudopleuronectes americanus GWPDVPKRKRKNSQCSM Winter flounder
gi|197111718|gb|ACH43023.1| Amphiprion melanopus GWPDVPKRKRKNSQCSV Cinnamon clownfish
gi|554866029|ref|XP_005943045.1| Haplochromis burtoni GWPDVPKRKRKNSQCSV African cichlid
gi|554866027|ref|XP_005943044.1| Haplochromis burtoni GWPDVPKRKRKNSQCSV African cichlid
gi|155968659|dbj|BAF75791.1| Leucopsarion petersii GWPDVPKRKRKNSQCSV Goby
gi|542179462|ref|XP_005468632.1| Oreochromis niloticus GWPDVPKRKRKNSQCSV Nile tilapia
gi|542179443|ref|XP_005468631.1| Oreochromis niloticus GWPDVPKRKRKNSQCSV Nile tilapia
gi|548516875|ref|XP_005751049.1| Pundamilia nyererei GWPDVPKRKRKNSQCSV Lake Victoria cichlid
gi|548516868|ref|XP_005751048.1| Pundamilia nyererei GWPDVPKRKRKNSQCSV Lake Victoria cichlid
gi|158962495|dbj|BAF91725.1| Solea senegalensis GWPDVPKRKRKNSQCSV Senegal sole
gi|657554893|ref|XP_008281931.1| Stegastes partitus GWPDVPKRKRKNSQCSV Bicolor damselfish
gi|657554891|ref|XP_008281930.1| Stegastes partitus GWPDVPKRKRKNSQCSV Bicolor damselfish
gi|584021005|ref|XP_006805181.1| Neolamprologus brichardi GWPEVPKRKRKNSQCSV Lake Tanganyika cichlid
gi|584021003|ref|XP_006805180.1| Neolamprologus brichardi GWPEVPKRKRKNSQCSV Lake Tanganyika cichlid
gi|379698079|dbj|BAL70326.1| Ambystoma mexicanum KRWLDGKRKRKNSQCLL Axolotl
gi|33413868|gb|AAO47435.1| Ambystoma mexicanum KRWLDGKRKRKNSQCLL Axolotl
gi|51491323|emb|CAA76327.2| Necturus maculosus KRWLDGKRKRKNSQCLL Common mudpuppy
gi|379698083|dbj|BAL70328.1| Ichthyophis kohtaoensis KRWLDGKRKRKSSQCVL Koa Tao Island caecilian
gi|387912440|dbj|BAM15695.1| Glandirana rugosa KRWPDGKRKRKNSQCMG Japanese wrinkled frog
gi|531032384|gb|AGT55994.1| Pelophylax nigromaculatus KRWPDGKRKRKNSQCMG Dark-spotted frog
gi|213654|gb|AAA16902.1| Rana catesbeiana KRWPDGKRKRKNSQCMG American bullfrog
gi|643358010|gb|AIA98429.1| Rana chensinensis KRWPDGKRKRKNSQCMG Asiatic grass frog
gi|357967150|gb|AET97635.1| Rana clamitans KRWPDGKRKRKNSQCMG Northern green frog
gi|189514197|gb|ACE07028.1| Xenopus (Silurana) tropicalis KRWPDGKRKRKNSQCMG Western clawed frog
gi|91754110|dbj|BAE93230.1| Xenopus (Silurana) tropicalis KRWPDGKRKRKNSQCMG Western clawed frog
gi|213623681|gb|AAI70077.1| Xenopus laevis KRWPDGKRKRKNSQCMG African clawed frog
gi|214832|gb|AAA49970.1| Xenopus laevis KRWPDGKRKRKNSQCMG African clawed frog
gi|214830|gb|AAA49969.1| Xenopus laevis KRWPDGKRKRKNSQCMG African clawed frog
gi|1377893|gb|AAC38034.1| Xenopus laevis KRWPDGKRKRKNSQCMG African clawed frog
gi|379697624|dbj|BAL70322.1| Xenopus laevis KRWPDGKRKRKNSQCMG African clawed frog
gi|65142|emb|CAA35252.1| Xenopus laevis KRWPDGKRKRKNSQCMG African clawed frog
gi|557011719|ref|XP_006006444.1| Latimeria chalumnae KRWSDGKRKRKNSQCSV West Indian Ocean 
gi|295414064|gb|ADG08191.1| Monodelphis domestica NRSLDGKRKRKTSQCSL Gray short-tailed oppossum
gi|295414062|gb|ADG08190.1| Potorous tridactylus NRSLDGKRKRKTSQCSL Long-nosed potoroo
gi|565312425|gb|ETE65008.1| Ophiophagus hannah PLWPDGKRKRKSSQCSV King cobra
gi|637314774|ref|XP_008111558.1| Anolis carolinensis QEWPDGKRKRKSSQCSV Carolina anole (lizard)
gi|554805544|ref|XP_005913715.1| Haplochromis burtoni QWLNGPKRKRKNSQCSV African cichlid
gi|582979235|gb|AHI45081.1| Lateolabrax japonicus QWLNGPKRKRKNSQCSV Japanese seabass
gi|583996540|ref|XP_006793380.1| Neolamprologus brichardi QWLNGPKRKRKNSQCSV Lake Tanganyika cichlid
gi|542230410|ref|XP_005453839.1| Oreochromis niloticus QWLNGPKRKRKNSQCSV Nile tilapia
gi|42794038|dbj|BAD11772.1| Oryzias latipes QWLNGPKRKRKNSQCSV Japanese rice fish (medaka)
gi|658905812|ref|XP_008435619.1| Poecilia reticulata QWLNGPKRKRKNSQCSV Guppy
gi|551486415|ref|XP_005794787.1| Xiphophorus maculatus QWLNGPKRKRKNSQCSV Southern platyfish
gi|528474265|ref|XP_005164043.1| Danio rerio QWPNGVKRKRKNSQCSM Zebrafish
gi|182889166|gb|AAI64729.1| Danio rerio QWPNGVKRKRKNSQCSM Zebrafish
gi|538774582|dbj|BAN82440.1| Anguilla japonica RWLDGPKRKRKNSQCSV Japanese eel
gi|538774578|dbj|BAN82439.1| Anguilla japonica RWLDGPKRKRKNSQCSV Japanese eel
gi|50080136|dbj|BAD27474.1| Conger myriaster RWLDGPKRKRKNSQCSV Whitespotted conger
gi|50080134|dbj|BAD27473.1| Conger myriaster RWLDGPKRKRKNSQCSV Whitespotted conger
gi|528496045|ref|XP_005156280.1| Danio rerio RWLDGPKRKRKNSQCSV Zebrafish
gi|528496043|ref|XP_001921013.4| Danio rerio RWLDGPKRKRKNSQCSV Zebrafish
gi|573901136|ref|XP_006638295.1| Lepisosteus oculatus RWLDGSKRKRKNSQCSV Spotted gar
gi|657754228|ref|XP_008312640.1| Cynoglossus semilaevis RWLNGPKRKRKNSQCSV Tongue sole
gi|551703633|gb|AGY36895.1| Synechogobius ommaturus RWLNGPKRKRKNSQCSV Asian freshwater goby
gi|551703629|gb|AGY36893.1| Tachysurus fulvidraco RWLNGTKRKRKNSQCSM Yellowhead catfish
gi|5052740|gb|AAD38689.1| Salmo salar RWPDGPKRKRKNSTCSV Atlantic salmon
gi|551520757|ref|XP_005811869.1| Xiphophorus maculatus RWPDVPKRKRKNSQCSL Southern platyfish
gi|617450251|ref|XP_007568330.1| Poecilia formosa RWPDVPKRKRKNSQCSM Amazon molly
gi|554866031|ref|XP_005943046.1| Haplochromis burtoni RWPDVPKRKRKNSQCSV African cichlid
gi|542179466|ref|XP_005468633.1| Oreochromis niloticus RWPDVPKRKRKNSQCSV Nile tilapia
gi|548517341|ref|XP_005751050.1| Pundamilia nyererei RWPDVPKRKRKNSQCSV Lake Victoria cichlid
gi|657554895|ref|XP_008281932.1| Stegastes partitus RWPDVPKRKRKNSQCSV Bicolor damselfish
gi|551703637|gb|AGY36897.1| Synechogobius ommaturus RWPDVPKRKRKNSQCSV Asian freshwater goby
gi|584021009|ref|XP_006805183.1| Neolamprologus brichardi RWPEVPKRKRKNSQCSV Lake Tanganyika cichlid
gi|584021007|ref|XP_006805182.1| Neolamprologus brichardi RWPEVPKRKRKNSQCSV Lake Tanganyika cichlid
gi|76786382|gb|ABA54942.1| Carassius auratus RWPNGVKRKRKNSQCSM Goldfish
gi|62526619|gb|AAX84684.1| Carassius auratus RWPNGVKRKRKNSQCSM Goldfish
gi|528474263|ref|XP_005164042.1| Danio rerio RWPNGVKRKRKNSQCSM Zebrafish
gi|657577797|ref|XP_008292746.1| Stegastes partitus RWRNGPKRKRKNSQCSV Bicolor damselfish
gi|637314769|ref|XP_008111557.1| Anolis carolinensis SRWPDGKRKRKSSQCSV Carolina anole (lizard)
gi|675417730|ref|XP_008922192.1| Manacus vitellinus TRGLDGKRKRKSSQCLV Golden-collared mannakin
gi|440904252|gb|ELR54791.1| Bos mutus TRSPDGKRKRKNGQCSL Yak
gi|548508922|ref|XP_005693826.1| Capra hircus TRSPDGKRKRKNGQCSL Domestic goat
gi|548508920|ref|XP_005693825.1| Capra hircus TRSPDGKRKRKNGQCSL Domestic goat
gi|674043466|ref|XP_008827648.1| Nannospalax galili TRSPDGKRKRKNGQCSL
Northern Israeli blind 
subterranean mole rat
gi|1136116|emb|CAA92650.1| Ovis aries TRSPDGKRKRKNGQCSL Sheep
gi|556738522|ref|XP_005964833.1| Pantholops hodgsonii TRSPDGKRKRKNGQCSL Tibetan antelope
gi|589917145|ref|XP_006971887.1| Peromyscus maniculatus bairdii TRSPDGKRKRKNGQCSL Prairie deer mouse
gi|589917143|ref|XP_006971886.1| Peromyscus maniculatus bairdii TRSPDGKRKRKNGQCSL Prairie deer mouse
gi|2582637|emb|CAA05339.1| Aptenodytes patagonicus TRWLDGKRKRKSSQCLV King penguin
gi|1107558|emb|CAA90411.1| Cairina moschata TRWLDGKRKRKSSQCLV Muscovy duck
gi|669260965|ref|XP_008634438.1| Corvus brachyrhynchos TRWLDGKRKRKSSQCLV American crow
gi|525024729|ref|XP_005059833.1| Ficedula albicollis TRWLDGKRKRKSSQCLV Collared flycatcher
gi|543376551|ref|XP_005531484.1| Pseudopodoces humilis TRWLDGKRKRKSSQCLV Ground tit
gi|2582814|emb|CAA05310.1| Pygoscelis adeliae TRWLDGKRKRKSSQCLV Adelie penguin
gi|530604890|ref|XP_005294177.1| Chrysemys picta bellii TRWLDGKRKRKSSQCSV Painted turtle
gi|564263988|ref|XP_006270847.1| Alligator mississippiensis TRWPDGKRKRKSSQCSV American alligator
gi|557279113|ref|XP_006022601.1| Alligator sinensis TRWPDGKRKRKSSQCSV Chinese alligator
gi|112806968|dbj|BAF03080.1| Eublepharis macularius TRWPDGKRKRKSSQCSV Leopard gecko
gi|602627599|ref|XP_007420744.1| Python bivittatus TRWPDGKRKRKSSQCSV Burmese python
gi|76786384|gb|ABA54943.1| Carassius auratus WWPDGVKRKRKNSQCSL Goldfish
5.3 Construct Sequences
The following five pages contain the construct sequences for the modified luciferase
assay system in FASTA format. Before the start of each construct is a key indicating
the coloration of features of interest.
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KEY: 
Restriction Site 
TALE8 
5SDM Mutations 
 
>pCMV6.AC-TALE8-[NLS-2]-5SDM 
AACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTG
CGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCC
AGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGCCAAGCTGATCTATACATTGAATCAATATT
GGCAATTAGCCATATTAGTCATTGGTTATATAGCATAAATCAATATTGGCTATTGGCCATTGCATACGTTG
TATCTATATCATAATATGTACATTTATATTGGCTCATGTCCAATATGACCGCCATGTTGACATTGATTATT
GACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACAT
AACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTAT
GTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCA
CTTGGCAGTACATCAAGTGTATCATATGCCAAGTCCGCCCCCTATTGACGTCAATGACGGTAAATGGCCCG
CCTGGCATTATGCCCAGTACATGACCTTACGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATC
GCTATTACCATGGTGATGCGGTTTTGGCAGTACACCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATT
TCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAAT
GTCGTAATAACCCCGCCCCGTTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGA
GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGA
TCCGGTACCGAGGAGATCTGCCGCCGCGATCGCCGGCGCGCCAGATCTCAAGCTTATGGATCCTATAAGGA
GCAGAACACCATCCCCAGCAAGAGAACTCCTTCCAGGGCCACAGCCAGACGGCGTGCAGCCAACTGCTGAT
CGGGGGGTGTCACCCCCCGCAGGTGGCCCGCTGGACGGTTTGCCCGCCAGAAGAACCATGAGCAGAACACG
CTTGCCAAGCCCACCAGCACCCTCCCCTGCCTTTAGCGCAGGCTCATTTTCAGATTTGTTGCGACAGTTTG
ACCCTTCTCTTTTCAACACCTCTCTGTTTGACAGCCTGCCTCCCTTCGGTGCTCATCACACAGAAGCCGCT
ACAGGTGAGTGGGACGAGGTTCAGTCAGGCCTCAGGGCCGCGGATGCCCCTCCCCCCACAATGAGAGTGGC
AGTGACCGCTGCTAGACCTCCCCGCGCCAAGCCTGCCCCTCGCAGGCGGGCCGCTCAGCCCTCAGACGCGA
GCCCCGCAGCTCAGGTCGATTTGAGAACACTCGGTTATAGCCAACAGCAACAAGAGAAGATTAAACCTAAG
GTTAGATCTACAGTGGCTCAGCACCACGAGGCCTTGGTCGGTCATGGGTTTACACACGCACATATCGTTGC
GCTGAGCCAACATCCTGCCGCTCTGGGGACGGTGGCCGTCAAGTATCAGGACATGATAGCCGCGTTGCCCG
AGGCCACACACGAAGCTATTGTCGGAGTGGGCAAGCAGTGGTCTGGGGCCAGAGCCCTCGAGGCTCTGCTG
ACCGTGGCTGGCGAGCTCAGGGGCCCTCCACTGCAATTGGACACTGGGCAGCTGCTTAAGATCGCCAAAAG
GGGGGGGGTCACGGCGGTAGAAGCTGTACACGCCTGGAGGAATGCCCTGACCGGGGCCCCCCTCAACCTCA
CCCCTGAACAGGTCGTTGCCATAGCCTCCAATATTGGTGGTAAACAGGCCCTCGAAACCGTGCAGGCCCTG
CTCCCCGTCCTGTGCCAAGCTCACGGACTCACTCCTCAGCAGGTCGTTGCTATCGCGTCAAATGGAGGGGG
GAAGCAGGCCCTGGAAACCGTGCAGAGATTGCTCCCCGTCCTGTGTCAGGCGCACGGCCTTACGCCTGAAC
AGGTTGTGGCCATTGCATCAAATATCGGCGGCAAGCAGGCACTGGAAACAGTTCAGGCACTTCTGCCCGTG
CTGTGCCAGGCTCACGGCCTCACTCCCGAACAGGTAGTTGCCATTGCATCTCATGACGGCGGCAAGCAGGC
ACTGGAAACTGTCCAAAGACTGCTGCCGGTGCTTTGTCAGGCGCACGGCCTGACGCCCCAGCAGGTGGTGG
CGATTGCCAGTAATGGTGGAGGGAAGCAGGCTCTGGAAACCGTACAGCGGCTGCTGCCAGTGCTCTGCCAG
GCCCATGGCCTCACCCCTGAACAGGTCGTTGCCATAGCCTCCAATATTGGTGGTAAACAGGCCCTCGAAAC
CGTGCAGGCCCTGCTCCCCGTCCTGTGCCAAGCTCACGGACTCACTCCCCAGCAGGTCGTGGCTATTGCTA
GTAACGGCGGCGGCAAACAGGCCCTGGAAACTGTGCAGAGGCTGCTGCCGGTGTTGTGCCAGGCCCATGGG
CTCACACCCGAACAGGTGGTCGCTATTGCTTCCCATGATGGAGGCAAGCAGGCGCTGGAAACAGTACAGAG
ATTGCTGCCAGTGTTGTGTCAGGCGCACGGACTCACCCCGGAGCAAGTAGTTGCCATTGCTTCCCACGACG
GCGGCAAACAAGCCCTTGAAACTGTGCAGCGGCTCCTGCCTGTTCTTTGTCAGGCACACGGGCTTACTCCG
GAACAGGTTGTAGCGATCGCCAGCAATATCGGTGGTAAACAGGCCCTCGAAACAGTGCAGGCACTGCTCCC
AGTGCTGTGCCAAGCACATGGCCTCACCCCTGAACAGGTCGTTGCCATAGCCTCCAATATTGGTGGTAAAC
AGGCCCTCGAAACCGTGCAGGCCCTGCTCCCCGTCCTGTGCCAAGCTCACGGACTCACTCCCCAGCAGGTC
GTGGCTATTGCTAGTAACGGCGGCGGCAAACAGGCCCTGGAAACTGTGCAGAGGCTGCTGCCGGTGTTGTG
CCAGGCCCATGGGCTCACACCCGAACAGGTGGTCGCTATTGCTTCCCATGATGGAGGCAAGCAGGCGCTGG
AAACAGTACAGAGATTGCTGCCAGTGTTGTGTCAGGCGCACGGACTCACCCCGGAGCAAGTAGTTGCCATT
GCTTCCCACGACGGCGGCAAACAAGCCCTTGAAACTGTGCAGCGGCTCCTGCCTGTTCTTTGTCAGGCACA
CGGGCTTACTCCGGAACAGGTTGTAGCGATCGCCAGCAATATCGGTGGTAAACAGGCCCTCGAAACAGTGC
AGGCACTGCTCCCAGTGCTGTGCCAAGCACATGGCCTCACCCCTGAACAGGTCGTTGCCATAGCCTCCAAT
ATTGGTGGTAAACAGGCCCTCGAAACCGTGCAGGCCCTGCTCCCCGTCCTGTGCCAAGCTCACGGACTCAC
TCCCGAACAGGTAGTTGCCATTGCATCTCATGACGGCGGCAAGCAGGCACTGGAAACTGTCCAAAGACTGC
TGCCGGTGCTTTGTCAGGCGCACGGCCTGACGCCCCAGCAGGTGGTGGCGATTGCCAGTAATGGTGGAGGG
AAGCAGGCTCTGGAAACCGTACAGCGGCTGCTGCCAGTGCTCTGCCAGGCCCATGGCCTCACTCCTCAACA
GGTCGTGGCTATCGCGAGCAACGGCGGAGGCAGACCCGCCCTCGAATCAATTGTTGCCCAACTTAGCCGGC
CGGACCCAGCGCTGGCCGCTCTGACGAACGACCATCTTGTGGCCCTTGCCTGTTTGGGAGGCAGACCTGCA
CTGGATGCAGTGAAGAAAGGACTCCCCCACGCCCCGGCTCTTATCAAGAGAACAAATCGGAGGATCCCAGA
GAGGACGAGTCACCGGGTAGCCGACCATGCCCAGGTCGTCCGAGTCCTGGGATTCTTTCAATGTCATAGTC
ACCCAGCTCAGGCCTTCGATGATGCTATGACACAATTCGGTATGAGTCGGCACGGCCTGCTCCAGCTGTTC
AGGAGGGTCGGCGTCACCGAGCTTGAAGCGCGGTCCGGCACTTTGCCCCCAGCATCACAGAGATGGGACCG
GATTCTCCAGGCTTCTGGAATGAAGAGAGCAAAACCCTCTCCTACAAGCACTCAAACTCCCGACCAAGCAA
GCCTTCACGCTTTCGCTGACTCCCTGGAGCGGGACCTCGATGCCCCCTCCCCCATGCATGAAGGCGATCAG
ACAAGAGCATCCTCCCCTAAAAAGAAGAGAAAGGTGGATAGGGCTGTGACCGGTCCGAGCGCCCAGCAGAG
CTTCGAGGTCAGAGTCCCGGAGCAGCGAGATGCACTGCATCTGCCACTGTCCTGGCCGAAGAAAAAAAGAA
AGGTGACCAGTATAGGTGGGGGTCTGCCTGACCCCGGGACGCCTACCGCGGCTGATTTGGCTGCGAGCAGT
ACAGTGATGAGGGATGCACTGGATGATTTTGACCTTGATATGCTCGGATCCGATGCCCTGGATGACTTTGA
CCTGGACATGCTGGGATCTGACGCCCTGGACGATTTTGATCTTGACATGCTGGGAAGTGACGCCTTGGACG
ACTTTGACCTTGATATGCTTGAACTGCTTCCCCAGAGAGCCGAGGGGAGAGGAAGTCTTCTGACCTGCGGA
GACGTCGAAGAGAATCCTGGACCCGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGAGTTCAT
GCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCC
GCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGAC
ATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTT
GAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCG
TGACCCAGGACTCCTCCTTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCC
TCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGA
CGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCA
AGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTACCCGGCGCCTACAACGTCAACATCAAGTTGGACATC
ACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTCCACCGGCGG
CATGGACGAGCTGTACAAGTAATAATAAGCGGCCGCACTCGAGGTTTAAACGGCCGGCCGCGGTCATAGCT
GTTTCCTGAACAGATCaCGGGTGGCATCCCTGTGACCCCTCCCCAGTGCCTCTCCTGGCCCTGGAAGTTGC
CACTCCAGTGCCCACCAGCCTTGTCCTAATAAAATTAAGTTGCATCATTTTGTCTGACTAGGTGTCCTTCT
ATAATATTATGGGGTGGAGGGGGGTGGTATGGAGCAAGGGGCAAGTTGGGAAGACAACCTGTAGGGCCTGC
GGGGTCTATTGGGAACCAAGCTGGAGTGCAGTGGCACAATCTTGGCTCACTGCAATCTCCGCCTCCTGGGT
TCAAGCGATTCTCCTGCCTCAGCCTCCCGAGTTGTTGGGATTCCAGGCATGaATGACCAGGCTCAGCTAAT
TTTTGTTTTTTTGGTAGAGACGGGGTTTCACCATATTGGCCAGGCTGGTCTCCAACTCCTAATCTCAGGTG
ATCTACCCACCTTGGCCTCCCAAATTGCTGGGATTACAGGCGTGAACCACTGCTCCCTTCCCTGTCCTTCT
GATTTTAAAATAACTATACCAGCAGGAGGACGTCCAGACACAGCATAGGCTACCTGGCCATGCCCAACCGG
TGGGACATTTGAGTTGCTTGCTTGGCACTGTCCTCTCATGCGTTGGGTCCACTCAGTAGATGCCTGTTGAA
TTGGGTACGCGGCCAGCTTGGCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGC
AGGCAGAAGTATGCAAAGCATGaATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAG
CAGGCAGAAGTATGCAAAGCATGaATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATC
CCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGA
GGCCGAGGCCGCCTCGGCCTCTGAGCTATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTT
GCAAAAAGCTCaCGGGAGCTTGTATATCCATTTTCGGATCTGATCAAGAGACAGGATGAGGATCGTTTCGC
ATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTG
GGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTT
TTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCC
ACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGG
CGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATG
CAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAG
CGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGC
GCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCG
ATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGT
GTGGCCGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGC
TGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTG
ACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAG
ATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATG
ATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGG
TTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTT
TGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCTAGCTAGAGCTTGGCGTAATCA
TGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCAT
AAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTT
TCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGT
ATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATC
AGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAA
AAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCT
GACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGC
GTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCT
TTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTT
CGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCG
TCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAG
CGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTA
TTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACA
AACCACCGCTGGTAGCGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAG
ATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATG
AGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTAT
ATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTAT
TTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGC
CCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGC
CGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTG
TCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCC
CATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGT
TATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTG
ACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTC
AATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGC
GAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCT
TCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGG
AATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGG
GTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACA
TTTCCCCGAAAAGTGCCACCTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCG
CAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCA
CGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGG
CACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTT
TCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACC
CTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTG
ATTTAACAAAAATTTAACGCGAATTTT 
 
 
KEY: 
Restriction Site 
NLS-2 Variant 
 
>RN_NLS-2 
ATGCATGAAGGCGATCAGACAAGAGCATCCTCCgccaggtcaccagatggaaagcgaaaaaggaagaacgg
ccaatgtcccctgGATAGGGCTGTGACCGGTCCGAGCGCCCAGCAGAGCTTCGAGGTCAGAGTCCCGGAGC
AGCGAGATGCACTGCATCTGCCACTGTCCTGGgccaggtcaccagatggaaagcgaaaaaggaagaacggc
caatgtcccctgACCAGTATAGGTGGGGGTCTGCCTGACCCCGGG 
 
>v-ErbA_NLS-2 
ATGCATGAAGGCGATCAGACAAGAGCATCCTCCactcggtggctggatggcaagcacaaaagaaagagcag
ccaatgtttggtgGATAGGGCTGTGACCGGTCCGAGCGCCCAGCAGAGCTTCGAGGTCAGAGTCCCGGAGC
AGCGAGATGCACTGCATCTGCCACTGTCCTGGactcggtggctggatggcaagcacaaaagaaagagcagc
caatgtttggtgACCAGTATAGGTGGGGGTCTGCCTGACCCCGGG 
 
 
KEY:  
Restriction Site 
TALE8 Recognition Site 
Min TATA 
Kozak Consensus 
 
>pGL4.10-TALE8P 
GGCCTAACTGGCCGGTACCTATACTATCCAATCCAACTTACTAGAGTGACGCCGGTGACGCCGACTAGAGT
GACGCCGGTGACGCCGACTAGAGTGACGCCGGTGACGCCGACTAGAGTCCACTTCGCATATTAAGGTGACG
CGTGTGGCCTCGAACACCGAGCGACCCTGCACCCGCCGCCACCATGGAGAAGCTTGGCAATCCGGTACTGT
TGGTAAAGCCACCATGGAAGATGCCAAAAACATTAAGAAGGGCCCAGCGCCATTCTACCCACTCGAAGACG
GGACCGCCGGCGAGCAGCTGCACAAAGCCATGAAGCGCTACGCCCTGGTGCCCGGCACCATCGCCTTTACC
GACGCACATATCGAGGTGGACATTACCTACGCCGAGTACTTCGAGATGAGCGTTCGGCTGGCAGAAGCTAT
GAAGCGCTATGGGCTGAATACAAACCATCGGATCGTGGTGTGCAGCGAGAATAGCTTGCAGTTCTTCATGC
CCGTGTTGGGTGCCCTGTTCATCGGTGTGGCTGTGGCCCCAGCTAACGACATCTACAACGAGCGCGAGCTG
CTGAACAGCATGGGCATCAGCCAGCCCACCGTCGTATTCGTGAGCAAGAAAGGGCTGCAAAAGATCCTCAA
CGTGCAAAAGAAGCTACCGATCATACAAAAGATCATCATCATGGATAGCAAGACCGACTACCAGGGCTTCC
AAAGCATGTACACCTTCGTGACTTCCCATTTGCCACCCGGCTTCAACGAGTACGACTTCGTGCCCGAGAGC
TTCGACCGGGACAAAACCATCGCCCTGATCATGAACAGTAGTGGCAGTACCGGATTGCCCAAGGGCGTAGC
CCTACCGCACCGCACCGCTTGTGTCCGATTCAGTCATGCCCGCGACCCCATCTTCGGCAACCAGATCATCC
CCGACACCGCTATCCTCAGCGTGGTGCCATTTCACCACGGCTTCGGCATGTTCACCACGCTGGGCTACTTG
ATCTGCGGCTTTCGGGTCGTGCTCATGTACCGCTTCGAGGAGGAGCTATTCTTGCGCAGCTTGCAAGACTA
TAAGATTCAATCTGCCCTGCTGGTGCCCACACTATTTAGCTTCTTCGCTAAGAGCACTCTCATCGACAAGT
ACGACCTAAGCAACTTGCACGAGATCGCCAGCGGCGGGGCGCCGCTCAGCAAGGAGGTAGGTGAGGCCGTG
GCCAAACGCTTCCACCTACCAGGCATCCGCCAGGGCTACGGCCTGACAGAAACAACCAGCGCCATTCTGAT
CACCCCCGAAGGGGACGACAAGCCTGGCGCAGTAGGCAAGGTGGTGCCCTTCTTCGAGGCTAAGGTGGTGG
ACTTGGACACCGGTAAGACACTGGGTGTGAACCAGCGCGGCGAGCTGTGCGTCCGTGGCCCCATGATCATG
AGCGGCTACGTTAACAACCCCGAGGCTACAAACGCTCTCATCGACAAGGACGGCTGGCTGCACAGCGGCGA
CATCGCCTACTGGGACGAGGACGAGCACTTCTTCATCGTGGACCGGCTGAAGAGCCTGATCAAATACAAGG
GCTACCAGGTAGCCCCAGCCGAACTGGAGAGCATCCTGCTGCAACACCCCAACATCTTCGACGCCGGGGTC
GCCGGCCTGCCCGACGACGATGCCGGCGAGCTGCCCGCCGCAGTCGTCGTGCTGGAACACGGTAAAACCAT
GACCGAGAAGGAGATCGTGGACTATGTGGCCAGCCAGGTTACAACCGCCAAGAAGCTGCGCGGTGGTGTTG
TGTTCGTGGACGAGGTGCCTAAAGGACTGACCGGCAAGTTGGACGCCCGCAAGATCCGCGAGATTCTCATT
AAGGCCAAGAAGGGCGGCAAGATCGCCGTGTAATAATTCTAGAGTCGGGGCGGCCGGCCGCTTCGAGCAGA
CATGATAAGATACATTGATGAGTTTGGACAAACCACAACTAGAATGCAGTGAAAAAAATGCTTTATTTGTG
AAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTGCAATAAACAAGTTAACAACAACAATTGC
ATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATG
TGGTAAAATCGATAAGGATCCGTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGG
GCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCC
GGCAGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCA
GCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAA
AGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCG
TTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTC
GCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGT
CTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTAT
TTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAA
ACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGA
AGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCA
TGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGT
ATATATGAGTAAACTTGGTCTGACAGCGGCCGCAAATGCTAAACCACTGCAGTGGTTACCAGTGCTTGATC
AGTGAGGCACCGATCTCAGCGATCTGCCTATTTCGTTCGTCCATAGTGGCCTGACTCCCCGTCGTGTAGAT
CACTACGATTCGTGAGGGCTTACCATCAGGCCCCAGCGCAGCAATGATGCCGCGAGAGCCGCGTTCACCGG
CCCCCGATTTGTCAGCAATGAACCAGCCAGCAGGGAGGGCCGAGCGAAGAAGTGGTCCTGCTACTTTGTCC
GCCTCCATCCAGTCTATGAGCTGCTGTCGTGATGCTAGAGTAAGAAGTTCGCCAGTGAGTAGTTTCCGAAG
AGTTGTGGCCATTGCTACTGGCATCGTGGTATCACGCTCGTCGTTCGGTATGGCTTCGTTCAACTCTGGTT
CCCAGCGGTCAAGCCGGGTCACATGATCACCCATATTATGAAGAAATGCAGTCAGCTCCTTAGGGCCTCCG
ATCGTTGTCAGAAGTAAGTTGGCCGCGGTGTTGTCGCTCATGGTAATGGCAGCACTACACAATTCTCTTAC
CGTCATGCCATCCGTAAGATGCTTTTCCGTGACCGGCGAGTACTCAACCAAGTCGTTTTGTGAGTAGTGTA
TACGGCGACCAAGCTGCTCTTGCCCGGCGTCTATACGGGACAACACCGCGCCACATAGCAGTACTTTGAAA
GTGCTCATCATCGGGAATCGTTCTTCGGGGCGGAAAGACTCAAGGATCTTGCCGCTATTGAGATCCAGTTC
GATATAGCCCACTCTTGCACCCAGTTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCGGGGTGTGCAA
AAACAGGCAAGCAAAATGCCGCAAAGAAGGGAATGAGTGCGACACGAAAATGTTGGATGCTCATACTCGTC
CTTTTTCAATATTATTGAAGCATTTATCAGGGTTACTAGTACGTCTCTCAAGGATAAGTAAGTAATATTAA
GGTACGGGAGGTATTGGACAGGCCGCAATAAAATATCTTTATTTTCATTACATCTGTGTGTTGGTTTTTTG
TGTGAATCGATAGTACTAACATACGCTCTCCATCAAAACAAAACGAAACAAAACAAACTAGCAAAATAGGC
TGTCCCCAGTGCAAGTGCAGGTGCCAGAACATTTCTCT 
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